Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹252.37
2.54 (1.02%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹11.44K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
26.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹155+62.8%
52W High₹270.6-6.7%
Current Price
₹252.37
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹201.90
Upper Circuit₹302.84
Reference Price
₹252.37
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹207.81
Inverse Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹246.6
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 48.67 (BUY) with 89.0% confidence
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
89%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
233.95
EMA50
212.91
EMA200
198.05
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹265.83
₹270.60
Support (Below)
₹249.50
₹235.90
₹201.30
₹197.80
₹195.09
Volume Analysis
TrendDECREASING
Change-61.80%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹249.85
3% Risk₹244.80
5% Risk₹239.75
7% Risk (Custom)
₹234.70Technical Levels
1x ATR (Volatility)₹239.96
2x ATR (Swing)₹227.55
3x ATR (Trend)₹215.14
Immediate Support₹249.50
Moving Averages
EMA 9 (Short-term)₹244.50
EMA 20 (Medium-term)₹233.95
EMA 50 (Trend)₹212.91
EMA 200 (Long-term)₹198.05
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹700.1 Cr | ₹620 Cr | ₹720.4 Cr | ₹754.4 Cr |
| Net Profit | ₹90.5 Cr | ₹58.3 Cr | ₹98.3 Cr | ₹113.2 Cr |
| EPS | — | ₹1.29 | ₹2.17 | ₹2.50 |
| Operating Profit | ₹142.3 Cr | ₹105.8 Cr | ₹166.1 Cr | ₹180.9 Cr |
ROE
15.43%
ROCE
18.49%
Debt/Equity
0.13
Current Ratio
4.62
OPM
23.98%
NPM
15.01%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 01 Aug 2025 | Dividend - Re 0.80 Per Share | DIVIDEND |
| 17 Sept 2024 | Dividend - Rs 0.60 Per Share | DIVIDEND |
| 07 Jun 2023 | Dividend - Re 0.50 Per Share | DIVIDEND |
| 19 Aug 2022 | Annual General Meeting/Dividend - Rs 0.25 Per Share | AGM |
| 15 Sept 2021 | Annual General Meeting/Dividend - Rs 0.25 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for MARKSANS
View All
positive
NDTV Profit 3d ago
Five Stocks To Buy: Dixon Tech, Belrise Industries, Marksans Pharma And More | June 10, 2026
Top picks include blue-chip electronics manufacturers, expanding auto components players, mid-tier pharma exporters, and major private and public sector banking stocks.
BELRISEBLUECHIPDIXONLGEINDIAMARKSANSNDRAUTOSDL26BEESTECHZTECHAutomobile and Auto ComponentsConsumer Durables
positive
CNBC TV18 - Markets 12d ago
Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition
Marksans Pharma said it has signed a definitive agreement to acquire 100% of QliniQ's share capital. The acquisition is expected to bolster the company's forward-integration strategy by providing direct sales, marketing and distribution capabilities in the European Union.
AKCAPITCPCAPMARKSANSFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 18d ago
Marksans Pharma soars after Q4 PAT jumps 64% YoY
Marksans Pharma surged 13.13% to Rs 249.19 after the company reported strong growth in quarterly earnings.
MARKSANSHealthcare